Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
TopAlliance Biosciences
University of Miami
Rutgers, The State University of New Jersey
Valerio Therapeutics
Valerio Therapeutics
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Case Comprehensive Cancer Center